Literature DB >> 25905633

Correction: A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In Vivo.

Mahbuba Rahman, Annie P K Chan, Michelle J Tang, Isabella T Tai.   

Abstract

Entities:  

Year:  2015        PMID: 25905633      PMCID: PMC4408124          DOI: 10.1371/journal.pone.0127226

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The author list for this article should be corrected to list Dr. Michelle Tang as the third author. Michelle Tang’s inclusion as an author is in line with the recommendation of the University of British Columbia, which evaluated the contributions to this work. The revised author list should thus read as follows: Mahbuba Rahman, Annie P. K. Chan, Michelle J. Tang, Isabella T. Tai The affiliation for Michelle J Tang at the time of the study was: Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada; Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada The correct citation is: Rahman M, Chan APK, Tang MJ, Tai IT (2011) A Peptide of SPARC Interferes with the Interaction between Caspase8 and Bcl2 to Resensitize Chemoresistant Tumors and Enhance Their Regression In Vivo. PLoS ONE 6(11): e26390. doi:10.1371/journal.pone.0026390 The Authors Contributions should also be revised as below: Conceived and designed the experiments: ITT, MT. Performed the experiments: MR APKC, MT. Analyzed the data: MR APKC ITT, MT. Contributed reagents/materials/analysis tools: ITT. Wrote the paper: ITT, MT.
  1 in total

1.  A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo.

Authors:  Mahbuba Rahman; Annie P K Chan; Michelle Tang; Isabella T Tai
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

  1 in total
  1 in total

1.  Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis.

Authors:  Ru Huang; Wenchao Gu; Bin Sun; Lei Gao
Journal:  Mol Med Rep       Date:  2018-03-01       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.